Acute kidney injury market seen reaching $7.78 billion by 2030

The acute kidney injury market is projected to grow from $5.72 billion in 2025 to $7.78 billion by 2030, according to The Business Research Company. The report points to rising diabetes, better early detection, and expanding renal care infrastructure as key drivers, with North America leading today and Asia-Pacific expected to grow fastest.

Why it matters: - Acute kidney injury is tied to serious, fast-moving kidney complications that can build up waste, fluids and electrolytes in the body within hours or days. - The market outlook matters because more effective detection and treatment could improve outcomes for patients with diabetes, hypertension and other high-risk conditions.

What happened: - The Business Research Company published The Acute Kidney Injury Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report projects the acute kidney injury market will rise from $5.72 billion in 2025 to $6.09 billion in 2026. - The same report forecasts the market will reach $7.78 billion by 2030. - The report uses a 6.5% CAGR for the 2025-2026 period and a 6.3% CAGR through 2030. - The company made a free sample report available here. - The full report is available here.

The details: - Market growth in the recent period was supported by limited access to advanced kidney care, rising diabetes and hypertension rates, better hospital infrastructure, broader use of traditional dialysis and growing awareness of AKI complications. - Future growth is expected to come from advances in renal replacement therapies and new nephroprotective medicines. - The report also points to more ambulatory surgical centers, wider use of biomarkers for early AKI detection and AI-driven monitoring in kidney care. - Key trends highlighted in the report include more dialysis and pharmacological treatment, a rising global incidence of AKI, early diagnosis and biomarker research, growth in urinary implant applications and more minimally invasive AKI management. - AKI can result from reduced blood flow to the kidneys, direct tissue damage or blockages in the urinary tract. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth in the coming years. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - Diabetes is doing double duty here: it is one of the biggest demand drivers for AKI care, and AKI can also worsen metabolic and inflammatory conditions linked to insulin resistance and glucose control. - The report suggests the market is shifting from broad dialysis access toward earlier detection, more targeted therapies and more technology-assisted monitoring. - That mix points to a market that is becoming more specialized as hospitals and clinics look for faster diagnosis and better long-term renal management.

What's next: - The report expects biomarker adoption, nephroprotective drug development and AI monitoring to play larger roles in kidney care over the next several years. - Growth in ambulatory surgical centers could expand access to AKI-related care outside traditional hospital settings. - The company says its 2026 reports also include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards and market hotspot infographics.

The bottom line: - Acute kidney injury is moving from a treatment market dominated by dialysis toward one shaped by early detection, digital monitoring and newer drug therapies, with global revenue projected to keep climbing through 2030.